ASHBasic Materials · Specialty ChemicalsThe 12 Wall Street analysts covering Ashland, Inc. hold a median 12-month price target of $82 — +7.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 92 of 100 as at 13 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Ashland, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.
Quality (58): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Size (28): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on ASH, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +7.3% from it.
Of the 20 most recent actions, 8 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Nov 2026 | Wells Fargo | Maintains | Equal-Weight | $75 → $80 |
| 5 Nov 2026 | JP Morgan | Maintains | Overweight | $80 → $82 |
| 5 Oct 2026 | UBS | Maintains | Buy | $83 → $80 |
| 5 Oct 2026 | UBS | Maintains | Buy | — |
| 6 Aug 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 31 July 2026 | Wells Fargo | Maintains | Equal-Weight | $50 → $70 |
| 31 July 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 30 July 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 30 July 2026 | Evercore ISI Group | Maintains | In-Line | $60 → $73 |
| 30 July 2026 | UBS | Maintains | Buy | — |
| 30 July 2026 | UBS | Maintains | Buy | $75 → $83 |
| 29 July 2026 | BMO Capital | Maintains | Outperform | — |
| 29 July 2026 | BMO Capital | Maintains | Outperform | $68 → $75 |
| 29 July 2026 | Mizuho | Maintains | Outperform | — |
| 29 July 2026 | Mizuho | Maintains | Outperform | $75 → $77 |
| 10 July 2026 | JP Morgan | Maintains | Overweight | $65 → $75 |
| 10 July 2026 | JP Morgan | Maintains | Overweight | — |
| 10 June 2026 | UBS | Maintains | Buy | — |
| 6 May 2026 | Seaport Global | Upgrade | Buy | — |
| 30 Apr 2026 | JP Morgan | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
ASH appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 13 Nov 2026, Ashland, Inc. returned +48.0% against +13.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 5% of US stocks
Cheaper than 52% of US stocks
Cheaper than 44% of US stocks
Cheaper than 23% of US stocks
Higher than 39% of US stocks
Higher than 46% of US stocks
Higher than 41% of US stocks
Higher than 58% of US stocks
Higher than 47% of US stocks
Higher than 45% of US stocks
Higher than 55% of US stocks
Higher than 81% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Ashland, Inc. has a market value of $3.4B and an enterprise value of $4.5B.
Revenue in the twelve months to 30 June 2026: $1.8B. The latest quarter grew 4.4% year on year.
Net income over the same four quarters: $52.0M, a 2.8% net margin.
Diluted earnings per share, trailing twelve months: $1.13.
Free cash flow in the twelve months to 30 June 2026: $206.0M.
Ashland, Inc. spent $76.0M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 136.9×; forward P/E: 15.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.23%, paying out 107% of earnings.
Ashland, Inc. employs 2,800 people — $658K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Ashland, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Ashland’s 4QFY26 revenue and EBITDA largely met expectations. The company anticipates a turnaround in FY2027, citing pricing potential and the conclusion of cost restructuring, while reports indicate interest from industry players and private equity firms.
Why it matters — ASH watchers may follow the expected FY2027 improvement and reported interest from potential acquirers.
Ashland’s board declared a quarterly cash dividend of $0.42 per share on the company’s common stock.
Why it matters — ASH watchers may note the board’s declared quarterly cash distribution to common shareholders.
Ashland’s Q4 fiscal 2026 earnings and sales missed estimates despite volume growth and strong Personal Care demand. The company projected higher sales for fiscal 2027.
Why it matters — ASH watchers may note the quarterly estimate misses alongside segment demand and the company’s higher-sales projection for fiscal 2027.
Ashland reported higher sales and adjusted earnings for its fiscal fourth quarter. Growth in pharmaceutical and personal care products helped offset weaker manufacturing productivity in Specialty Additives.
Why it matters — ASH watchers may note both the growth in pharmaceutical and personal care products and the productivity weakness in Specialty Additives.
Ashland reported quarterly earnings of $1.12 per share, below the Zacks Consensus Estimate of $1.30. Earnings were $1.08 per share a year earlier.
Why it matters — ASH watchers may note that earnings missed the consensus estimate, despite being higher than a year ago.
The 12 Wall Street analysts covering Ashland, Inc. have a median 12-month price target of $82, with estimates ranging from $73 to $90. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 12 analysts covering Ashland, Inc., 9 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Ashland, Inc. 92 out of 100 across roughly 4,600 US stocks as at 13 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Nov 2026, Ashland, Inc. ranks 92 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).
No one can know that. What the data says: the median 12-month target from 12 analysts implies +7.3% from the last close, and Ticker Nerd's factor model ranks Ashland, Inc. 92 out of 100 as at 13 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Ashland, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ASH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $73 to $90 over the next 12 months.
Ashland, Inc. returned +48.0% over the 12 months to 13 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Ashland Inc. is a global additives and specialty ingredients company that supplies performance-focused materials for consumer and industrial applications.
The most recent item we track (Seeking Alpha, 13 Nov 2026): "Ashland: Focus On FY 2027 Financial Improvement And Potential Sale". Ashland’s 4QFY26 revenue and EBITDA largely met expectations. The company anticipates a turnaround in FY2027, citing pricing potential and the conclusion of cost restructuring, while reports indicate interest from industry players and private equity firms.
Ashland Inc. is a global additives and specialty ingredients company that supplies performance-focused materials for consumer and industrial applications. Its current business centers on life sciences, personal care, specialty additives, and intermediates and solvents, with products used in pharmaceuticals, food and beverage, architectural coatings, construction, energy, automotive, and other manufacturing markets. The company develops ingredients and formulation technologies such as excipients, binders, rheology modifiers, preservatives, and specialty solvents that help customers improve product stability, processing, texture, and performance. Ashland Inc. serves a broad international customer base across North America, Europe, Asia-Pacific, and other regions, working with manufacturers that require tailored chemistry for regulated and technical end markets. Headquartered in Wilmington, Delaware, Ashland Inc. is recognized in the specialty chemicals sector for focusing on high-value ingredients that support complex formulations across multiple industries.
CEO Mr. Guillermo Novo · 2,800 employees · United States · https://www.ashland.com
